Galaj · Pharmacology, biochemistry, and behavior 2020 · narrative review · n=?

Therapeutic efficacy of environmental enrichment for substance use disorders.

Cited 55 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review synthesizing preclinical animal models and qualitative clinical literature.

PubMed 31778722 · doi:10.1016/j.pbb.2019.172829 · record verified 2026-08-26

What was done

Narrative review surveying preclinical animal studies and clinical literature evaluating environmental enrichment as an intervention for substance use disorders, as well as associated neuroplastic mechanisms in the mesocorticolimbic system.

What was found

The abstract provides no quantitative metrics or effect sizes. Preclinical findings report that environmental enrichment introduced after drug exposure reduces compulsive drug-taking, diminishes drug reward and reinforcement, decreases behavioral control by drug cues, and prevents relapse. Clinical literature suggests multidimensional enrichment (encompassing physical activity, social interaction, vocational training, and community involvement) may offer similar benefits if delivered continuously and rigorously.

Why it matters

Synthesizes behavioral and neurobiological evidence supporting environmental enrichment as a non-pharmacological strategy to reduce craving and prevent relapse in substance use disorders.

Limits

The abstract contains no numerical data, study counts, or systematic review methodology. Much of the presented evidence derives from preclinical animal models, and the clinical efficacy, optimal protocols, and feasibility of continuous multidimensional enrichment in human populations are not quantified.

Cited by